Cancer-Killing virus trial launches for patients out of options
NCT ID NCT07128914
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called GO306, a modified virus designed to infect and destroy cancer cells. It is for adults with advanced solid tumors (like breast, colon, or kidney cancer) that have not responded to standard therapies. The main goal is to check the safety of the virus and find the best dose, with early signs of tumor shrinkage also being measured.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED REFRACTORY SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, 201620, China
-
Shenzhen Third People's Hospital
RECRUITINGShenzhen, Guangzhou, 518112, China
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a smart digital program restore sleep for cancer survivors?